BREAKTHROUGH GENOMICS’ Early Cancer Detection Tests use
patented DNA methylation technology to pick up faint cancer
signals that circulate in a person’s blood.

These cancer signals are able to be detected in the blood even at
extremely small concentrations and before a person may be
experiencing any symptoms of the cancer.

These tests enable early cancer detection, when cancer is still able to be successfully treated and cured.

Feature include:
– Non-invasive, blood-based tests
– High Sensitivity for Early Stage Detection
– Based on unique DNA Methylation Haplotype Blocks
– Advanced AI-based Data Analysis

Technology Partner: